• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    There are described compounds of the formula in which R1 is hydrogen or C1-6alkyl, R2 is hydrogen, C1-6alkyl or C3-6alkenyl, X and Y are each oxygen, sulphur, sulphinyl or sulphonyl, n is 2 to 6 and Z ist IH-tetrazol-5-yl, 1H-tetrazol-5-ylthio, 1H-tetrazol-5-ylsulphinyl, 1H-tetrazol-5-yl- sulphonyl, cyano or thiocyano, provided that when both X and Y are oxygen Z is 1H-tetrazol-5-ylthio, 1H-tetrazol-5-yl- sulphinyl, 1H-tetrazol-5-ylsulphonyl or thiocyano; and salts thereof. The compounds in which Z is other than cyano or thiocyano have pharmaceutical activity and inhibit leukotriene action or formation.
    公开号:SU1277892A3
    申请号:SU833656355
    申请日:1983-10-18
    公开日:1986-12-15
    发明作者:Помфрет Вердж Джон；Голдсворти Ждон；Стенли Маршалл Винстон
    申请人:Лилли Индастриз Лимитед (Фирма)；
    IPC主号:
    专利说明:


    04 31 Anhydrous dnmethylformamide (60 ml) was added sodium azide (2.96 g) and ammonium chloride (2.44 g) and the suspension was heated at 120 ° C for 2 hours. Then additional sodium azide (1.2 ml) was added. g) and ammonium chloride (1.0 g) and continue heating for another 2 hours. The reaction mixture is cooled, mixed with water (600 ml), the filtered substance is dried in vacuum, finally recrystallized from a mixture of ethanol and water (when bleaching with charcoal) and the title compound is obtained in the form of a beige solid, so pl. 160-162 ° C. Similarly, the following compounds are prepared: 4- | .2- (4-acetyl-3-hydroxy-2-propylphenoxy) ethylthio1-benzonitrile, m.p. lU-lie C, 1- 2-hydroxy-3-prop-1-4- 2- (4-) TH-tetrazol-5-yl- (phenylthio) -ethoxy; phenyl | -ethanone, m.p. 67-169 ° C. Example 2.1 2-hydroxy-Zylprop-4g-thioacetophenone. The indicated compound is prepared in analogy with Example 1 by performing steps I, II, and III, using 2,4-hydroxy-Propyl acetophenone as the starting material, mp. 70-72 S. and. 2-Oxy-3-prop-4- (3-chloroprrpylthio) -acetophenone. This compound is obtained in a manner similar to Example 1 (IV), using the product obtained in Step I of this Example. The compound obtained is liquid, b.p. 205 ° C at a pressure of 0.05 mm Hg III.4- (3 -) - 4-Acethyl-3-oxy-2-pro-pilfeniltio-benzonitrile. This compound is prepared analogously to example 1 (V), using 4-cyanophenol and the product obtained in stage II of this example, mp, 90-92 C. IV, - {2-hydroxy-3-propyl-4- 3- (4 -) 1H-tetrazol-5-yl- (phenoxy) -propylthio-phenyl-ethanone. This compound is prepared analogously to example 1 (Vl), using the benzonitrile obtained in stage III of this example, as a substrate, mp, 178-182 ° C. The following compounds are prepared analogously: (4-acetyl-3-hydroxy-2-propylphenylthio) -ethoxy-benzonitrile, m.p. 02-104c. 924 1- (2-hydroxy-3-propyl-4- 2- (4 -) - 1H tetrazol-5-yl- (phenoxy) -ethylthio-phenyl | ethanone, mp. 172-175 C. Example 3, I 4- (3-) 4-Acethyl-3-oxy-2-propylphenylthio- (propylthio) -benzonitpryl. This compound was prepared analogously to example 1 (V), but using 2-hydroxy3-propyl-4-thioacetophenone, mp okopo 804, II, -2-hydroxy-3-propyl-4- 3- (4-) 1H-tetrazol-5-yl- (phenylthio) -propylthio-phenyl-ethanone. This compound was prepared analogously to example 1 (Vl ) using benzonitrile obtained as stage I of this example, mp 160-162 0, Example 4, I- | 2-hydroxy-3-propyl-4- (4 -) -1 H-tetrazole 5-yl- (fensh1-sulfinyl) -propoxy5-f nylj-ethanone. 1 - {2-hydroxy-3-propyl-4-3- (4-.) -1H-tetrazol-5-yl (phenylthio) -propoxy phenyl-ethanone (0.412 g) dissolved in methanol (20 ml) and 20% aqueous hydrogen peroxide (0.7 ml) is added, the resulting solution is heated at reflux temperature for 36 h. Water (20 ml) is added, methanol is extracted in vacuum, the remaining aqueous phase is extracted with ethyl acetate (2 20 ml), the combined organic the extracts are dried over magnesium sulfate, evaporated in vacuo to give a pale yellow solid, which is recrystallized from ethanol / water (for both tsvechivanii charcoal) to give the sulfoxide as fine white crystals, m.p. with decomposition. Similarly, the following compound is obtained: 1- 2-Oxy-3-propyl-4-l2- (4 -) - l-tetrazol-5-yl- (phenylsulfinyl) -ethoxy-phenyl | -ethane, m.p. 128-130C. Example 5, 1- 2-hydroxy-3-propyl-4- 3- (4 -) - 1H-tetrazol-5-yl- (phenyl sulfonyl) -product si-phenyl 1 ethanone. The 1- (2-hydroxy-3-propyl-4- 3- (4-) - 1H-tetrazol-5-yl- (phenylthio) -propo xylene-ethanone (0.412 g) was dissolved. in glacial acetic acid (6 ml), 20% hydrogen peroxide (1 ml) is added to the mixture. The resulting solution is aggravated at 24 hours. 512 The reaction mixture is cooled, ayut, poured into water (75 ml) and intensively mixed for 30 minutes. The flocculent precipitate is collected by filtration, dried in a vacuum, then recrystallized from ethanol / water (upon bleaching with charcoal) and the desired sulfone is obtained as a white solid, mp. 120 ° C. The following compounds are prepared analogously: 1- {2-hydroxy-3-propyl-A- 3- (4-) - 1H-tetrazol-5-yl- (phenoxy) -propyl-sufonyl-phenyl | -ethane, mp -172 C 1- | 2-hydroxy-3-propyl-4- 2- (4 -) - 1H tetrazol-5-yl- (phenylsulfonyl) -ethoxy1-phenyl} -ethanone, m.p. 197-199 C Example 6. 1 - 2-hydroxy-3-propyl-4 (3 -) - 4-thiociaP1-phenoxy- (propoxy) -phenyl-ethanone. A mixture of 4- (3-chloropropoxy} -2-hydroxy-3 propyl acetophenone (4.06 g), 4-thiocyano phenol (IACS T.78, s.858) (2.25 g), sodium iodide (2.25 g and anhydrous sodium carbonate (6 g) is boiled and stirred at a temperature of de .. /.-g, reflux in methyl ethyl ketone 16U ml, on-anhydrous) 80 hours. The solvent is evaporated and the remaining mass is stirred with water (100 ml) and dichloromethane (00 ml). The organic layer is separated and the aqueous layers are extracted a second time with dichloromethane (100 ml). The two organic layers are combined, washed with water, and dried over hexane-free sulphate. After evaporation, 5.0 g of a yellow resin remain, which slowly crystallizes. It is recrystallized from a mixture of diethyl ether and petroleum ether to obtain 3.2 g of a white solid, mp, 85 C. Similarly, the following compound is obtained: - 2-hydroxy-3-propyl-4- (, 2 -) - 4 Thiociano (1 enoxy- (ethoxy) -phenyl-ethanone, t, rui. Example 7. 1 - 2-hydroxy-3-1 J-- nDOtil-4- L3- (4 -) - 1 H-tetraz L-5-ylthio (phenoxy) -propoxy-phenyl-ethanone, Mixture 1 - f 2-hydroxy - 3 - propyl-4- (3-) 4-thiocyanophenoxy- (propoxy) fenshe; ethanone (7.7 g; sodium azide (3.9 g and ammonium chloride (3.2 g), dissolved in water-free Dimethylformamide (40 ml), stirred and heated at a temperature of 1 1 5 s 4 h, 26 The mixture was poured into a mixture of ice and water (200 ml) and the pH was adjusted to 3.0 with 1 N hydrochloric acid, the result is a yellow precipitate, It is collected, washed with water and dissolved in 2N NaOH (80 ml). This solution is extracted twice with 40 ml of diethyl ether and the organic layers are drained. The aqueous layer is acidified with 5N. hydrochloric acid, resulting in a viscous solid precipitate. After crystallization from aqueous methanol, 5.9 g of a pale yellow solid are obtained, mp. 114 ° C. Similarly, the following compound is obtained: 1- {2-hydroxy-3-propyl-4- 2- (4-) - 1H-tetrazol-5-ylthio- (phenoxy) ethoxy-phenyl | -ethanone, i.e. . Example 8. 1- {2-hydroxy-3-propyl-4- 2- (4 -) - 1H-tetrazol-5-ylsulfonyl- (phenoxy) -ethoxy-phenyl-ethanone. , (-. -,, g- // ,,, 1-f 2-hydroxy-3-propyl-4- 2- (4-) - 1HC ... tetrazol-5-ylthio- | phenoxy) -ethoxy, , "T phenyl ethanone (1.85 g dissolved in ,,. J / t of glacial acetic acid. Hydrogen peroxide (100 vol., Ml) was added and the mixture was stirred and heated at 70 ° C for 6 h. The solvent was distilled off under vacuum and the residue is triturated with water to give a solid. After recrystallization from a mixture of diethyl ether and petroleum ether, 1.92 g of a white-white product is obtained, mp 100-102 C. In a similar manner, the following connection is obtained: 1 - {2 -OXI-3-PROPIL-4- 3- (4 -) - 1N tetrazol-5-yl sulfonyl-phenoxy) propoxy-phenyl} -ethane, so pl. 8850 ° C. The proposed compounds are pharmacologically active and are inhibitors of leukotriene, as shown by the following tests: a) an in vitro test on segments of the ileal guinea pig at (concentrations from 10 ng to 30 µg according to Schi.ld. 1947, Brit I. Fharir., 2, 197-206 (the pharmacological compounds of the following npHN; epoB showed less for I / ID 4 IU mol); b) in / Io test of the guinea pig lung function test / Uisten niid Dr47, :: n, 1974, .hitn T Vorl,
    权利要求:
    Claims (1)
    [1]
    Invention Formula
    The method of obtaining ethanone compounds. General formula I
    position, leukotrienes are med / X (CHR-VW A-7
    tpp mi-mnmtti tpp mn Rt nnvngtt chm; / /
    BUT GN-SzN
    bronchospasm initiators: allergic lung diseases (atonic asthma and industrial asthma), and in other inflammatory diseases associated with acute or chronic infections (allergic skin diseases caused by various causes of eczema, psoriasis, contact dermatitis, angioedema, bronchitis and cystic fibrosis and Sokolsky-Buyo disease).
    The active compounds are effective over a wide dosage range, for example, the daily dose is usually 0.5-300 mg / kg, and in the treatment of adults, preferably 5-100 mg / kg. The dose administered depends on the nature of the disease, the choice of compound and the method of its administration.
    40
    45
    50
    where h 2,3;
    Z is tetrazol-5-yl,
    X - oxygen,
    Y is sulfur, sulfinyl or sulfonyl;
    or X is sulfur or sulfonyl, and
    Y is oxygen;
    or X and Y are sulfur, characterized in that the compound of the formula I, where Z — CN is reacted with sodium azide, followed by the separation of the target product, and the compound of the formula I, where X is oxygen and Y is sulfur, is oxidized to obtain the compound of formula 1 in which Y is sulfinyl or sulfonyl, or
    Closest to the present invention, the compound of formula I, in which
    are compounds that include the group - X is sulfur, and Y is oxygen to produce phenoxyloxyphenyl derivatives, nor compounds of the formula I, where X is, for example, 4-3 (4-acetyl-3-hydroxy-2-sulfonyl.
    mp-phenoxy) propoxyl benzoyE {th acid.
    The LCg value when testing known compounds in the ileum segments of guinea pigs is 18 μmol, i.e. their activity is much less than the activity of the proposed compounds.
    Connection example LC
    1 (vi)
    1 (last connection)
    2 (ivL
    4 (last connection)
    50
    0.6
    0.8
    one
    5 (first additional connection) 7
    5 (second additional
    connection) 7
    The low toxicity of the target compounds according to examples 1,2,4 and 5 was determined, which was confirmed when they were administered to guinea pigs through the mouth in the form of an aerosol with a concentration of 1 mg / ml.
    Invention Formula
    The method of obtaining ethanone compounds. General formula I
    0
    five
    0
    where h 2,3;
    Z is tetrazol-5-yl,
    X - oxygen,
    Y is sulfur, sulfinyl or sulfonyl;
    or X is sulfur or sulfonyl, and
    Y is oxygen;
    or X and Y are sulfur, characterized in that the compound of the formula I, where Z — CN is reacted with sodium azide, followed by the separation of the target product, and the compound of the formula I, where X is oxygen and Y is sulfur, is oxidized to obtain the compound of formula 1 in which Y is sulfinyl or sulfonyl, or
    类似技术:
    公开号 | 公开日 | 专利标题
    DE69736777T2|2007-08-23|AMIDINOHYDRAZONE AS PROTEASE INHIBITORS
    EP0051829B1|1984-12-05|N-substituted omega-| alcanoic acids, salts and esters thereof, process for producing the same and these active agents containing pharmaceutical compounds
    WO1998034915A1|1998-08-13|N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases
    US8063100B2|2011-11-22|Process for the synthesis of strontium ranelate and its hydrates
    CS224629B2|1984-01-16|Method for producing new derivates of benzoyl-a alfa-hydroxybenzylphenylglykoside
    SU1277892A3|1986-12-15|Method of producing ethanon compounds
    NZ238168A|1995-07-26|Phenyl acetic acid ester derivatives, preparation and pharmaceutical compositions thereof
    US4857644A|1989-08-15|Aryl sulfonopiperazines as anti-inflammatory agents
    EP0151072B1|1988-03-09|Derivatives of methylenediphosphonic acid, process for their preparation and antirheumatic pharmaceutical compositions containing them
    US4992576A|1991-02-12|Intermediates for leukotriene antagonists
    US5189211A|1993-02-23|Sulfonamide derivatives
    EP0006789A1|1980-01-09|Bis(aryloxy-alcanecarboxylic compounds, their preparation and their therapeutic use
    US4024182A|1977-05-17|Preparation of aryl-butadienoic acids
    US4889866A|1989-12-26|Arylsulfonyl dihydropyridine derivatives
    US3337576A|1967-08-22|Arylthioalkyltetrazoles
    EP0233432B1|1989-03-15|Polyfluoralkylthiomethyl compounds, processes for their preparation and their use as tensio-active compounds or as precursors therefor
    PT92633A|1990-06-29|PROCESS FOR THE PREPARATION OF FURANIC CETONIC DERIVATIVES WITH ANTI-RETROVIRAL ACTION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
    RU2026293C1|1995-01-09|Method of synthesis of imidazole derivative
    CH625210A5|1981-09-15|
    JP2579532B2|1997-02-05|Aminoacetonitrile derivative and method for producing the same
    PL91828B1|1977-03-31|New 6-aza-3h-1,4-benzodiazepines[au4993172a]
    JPH0670013B2|1994-09-07|3-nitro-dihydropyridines
    PT87480B|1992-09-30|PROCESS FOR THE PREPARATION OF HISTAMINE H2 ANTAGONISTS FROM NEW INTERMEDIATE COMPOUNDS
    KR850000757B1|1985-05-25|Process for preparing thiazoline derivatives
    US4910216A|1990-03-20|2-|indole derivatives
    同族专利:
    公开号 | 公开日
    IL69996D0|1984-01-31|
    GB8328106D0|1983-11-23|
    FI833770A0|1983-10-17|
    CA1202632A|1986-04-01|
    PT77520B|1986-05-28|
    CS773383A2|1987-06-11|
    PH19395A|1986-04-10|
    KR840006480A|1984-11-30|
    PL139497B1|1987-01-31|
    RO87690B|1985-10-01|
    CS255856B2|1988-03-15|
    JPS5993041A|1984-05-29|
    HU187928B|1986-03-28|
    GR78697B|1984-09-27|
    US4595540A|1986-06-17|
    IE56113B1|1991-04-24|
    FI833770A|1984-04-22|
    EP0110541A1|1984-06-13|
    DK482983A|1984-04-22|
    HUT34458A|1985-03-28|
    RO87690A|1985-09-30|
    PT77520A|1983-11-01|
    GB2128999B|1986-07-02|
    ZA837749B|1984-11-28|
    DK482983D0|1983-10-20|
    AU2025783A|1984-05-03|
    DD212254A5|1984-08-08|
    IE832456L|1984-04-21|
    PL244215A1|1985-01-30|
    GB2128999A|1984-05-10|
    NZ206001A|1985-08-16|
    EG16423A|1987-10-30|
    US4740514A|1988-04-26|
    ES8505199A1|1985-05-16|
    BG40809A3|1987-02-16|
    ES526528A0|1985-05-16|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    FR2173778A1|1972-03-02|1973-10-12|Aries Robert|5-phenoxyalkyltetrazoles - hypocholesterolaemics and anorectics|
    DE2424742C3|1974-05-21|1982-04-22|Schering Ag, 1000 Berlin Und 4619 Bergkamen|Thiophene derivatives Process for their preparation and medicaments containing them|
    GB2058785B|1979-09-05|1983-05-25|Glaxo Group Ltd|Phenol derivatives|
    NZ194844A|1979-09-05|1983-07-29|Glaxo Group Ltd|Phenoxyalkoxyphenyl derivatives and pharmaceutical compositions|
    FI73423C|1980-02-29|1987-10-09|Otsuka Pharma Co Ltd|FRAMEWORK FOR THE FRAMEWORK OF PHARMACOLOGICAL VEHICLES TETRAZOLDERIVAT.|
    EP0056172B1|1981-01-09|1985-04-03|FISONS plc|Phenoxy- and thiophenoxy compounds, methods for their preparation and pharmaceutical formulations containing them|
    US4567201A|1981-11-25|1986-01-28|Takeda Chemical Industries, Ltd.|Diphenoxypropane derivatives and compositions of antiasthmatic and antiinflammatory agents thereof|
    US4499299A|1981-12-30|1985-02-12|Ici Americas Inc.|Pharmaceutically active phenylcarboxylic acid derivatives|
    US4585781A|1982-12-31|1986-04-29|Glaxo Group Limited|Heterocyclic derivatives|US5135940A|1982-09-23|1992-08-04|Merck Frosst Canada, Inc.|Leukotriene antagonists|
    US5105017A|1983-07-18|1992-04-14|Eli Lilly And Company|Leukotriene antagonist intermediates|
    US4990526A|1985-06-18|1991-02-05|Merck Frosst Canada, Inc.|Leukotriene antagonists, compositions and methods of use thereof|
    CA1309557C|1985-06-18|1992-10-27|Robert N. Young|Leukotriene antagonists|
    US4663332A|1985-10-10|1987-05-05|Hoffman-La Roche Inc.|5-substituted N-alkylated tetrazoles|
    US4774432A|1986-07-07|1988-09-27|Gte Products Corporation|Electric lamp with flexible cover holder|
    JP2006502143A|2002-08-26|2006-01-19|メルク　エンド　カムパニー　インコーポレーテッド|An acetophenone potentiator of metabotropic glutamate receptors|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    GB8230076|1982-10-21|
    [返回顶部]